Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.
Aino SiltariJarno RiikonenJuha KoskimäkiTomi PakarainenOtto O EttalaPeter BoströmHeikki SeikkulaAndres KotsarTeuvo TammelaMika HelminenPaavo V RaittinenTerho LehtimäkiMikkel FodePeter ØstergrenMichael BorreAntti RannikkoTimo MarttilaArto SalonenHanna RonkainenSven LöffelerTeemu J MurtolaPublished in: BMJ open (2022)
Clinicaltrial.gov: NCT04026230, Eudra-CT: 2016-004774-17, protocol code: ESTO2, protocol date 10 September 2020 and version 6.